# Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)

> **NCT00395473** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 141 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** MK0653, ezetimibe / Duration of Treatment: 6 Weeks

## Key facts

- **NCT ID:** NCT00395473
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** 2005-11
- **Final completion:** 2005-11
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00395473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00395473, "Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00395473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*